Pretherapy Ferumoxytol-enhanced MRI for Metastatic Breast Cancer: A New Approach for Predicting Tumor Delivery of Macromolecular Therapeutics?

Radiol Imaging Cancer. 2023 Mar;5(2):e220183. doi: 10.1148/rycan.220183.

Author

Heike E Daldrup-Link¹

Affiliation

¹ From the Department of Radiology, Stanford University, 725 Welch Rd, Room 1665, Stanford, CA 94305-5614; and Cancer Imaging and Early Detection Program, Stanford Cancer Institute, Stanford, Calif.

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms* / diagnostic imaging
Breast Neoplasms* / therapy
Contrast Media / administration & dosage
Female
Ferrosoferric Oxide* / administration & dosage
Humans
Irinotecan
Magnetic Resonance Imaging

Substances

Ferrosoferric Oxide
Irinotecan
Contrast Media

Grants and funding